PARP enzymes and androgen receptor — Drug Target
All drugs that target PARP enzymes and androgen receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
PARP inhibitor and androgen receptor inhibitor
Marketed (1)
- Talazoparib with enzalutamide · Pfizer · PARP inhibitor and androgen receptor inhibitor · Oncology